Clinical Trial Update: A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacodynamic and pharmacokinetic interaction between aliskiren and furosemide in patients with heart failure. The trial is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Lasix (furosemide)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2012-09-10